Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers Health (HIMS) Is Up 57.4% After Renewed Novo Nordisk GLP-1 Partnership - Has The Bull Case Changed?

Earlier this month, Hims & Hers Health, Inc. resolved its legal dispute with Novo Nordisk and entered a renewed collaboration…

Is HIMS a good stock to buy? We came across a bullish thesis on Hims & Hers Health, Inc. on…

Is HIMS a good stock to buy? We came across a?bullish thesis?on Hims & Hers Health, Inc. on TopSecretStocks’s Substack by…

Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks Making Huge Moves this Week. Hims & Hers…

Why Hims & Hers Health (HIMS) is on investors’ radarHims & Hers Health (HIMS) has drawn fresh attention after a…

Hims & Hers (HIMS) stock surged 57% this week to record its best weekly rise after reaching a deal with…

Hims & Hers Health (NYSE:HIMS) has agreed to acquire Australian digital health company Eucalyptus, advancing its international expansion beyond the…

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 11 Best Day Trading Stocks to Buy Now. Investment bank…

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 12 Most Shorted Stocks to Buy in 2026. On March…

Bloomberg journalists discuss todays biggest winners and losers in the stock market. Listen for analysis on the companies making news…

A new class action lawsuit alleges Hims & Hers falsely advertises its compounded GLP-1 semaglutide products as being the same…

Hims & Hers Health Inc. shares are on pace for their best week on record as a new partnership with…

Hims & Hers Health Inc. shares posted their best week on record as a new partnership with Novo Nordisk A/S…

Novo Nordisk dropped its lawsuit against Hims & Hers and launched a new collaboration. The deal is advantageous for both…

Hims & Hers Health, Inc. (HIMS) closed at $23.84 in the latest trading session, marking a -7.88% move from the…

Hims & Hers Health (NYSE:HIMS) launched the Hims & Hers Benefits program, expanding its subscription platform beyond prescriptions.The program gives…

Shares of Hims & Hers Health NYSE:HIMS climbed about 5% on Thursday morning after the telehealth company said it entered…

Beiser joins the telehealth company from Eli Lilly as it expands internationally and builds out its Phoenix operations.…

Hims & Hers shares extend gains as Eli Lilly warns impurity it discovered in compounded versions of its weight-loss drug…

Hims & Hers Health (NYSE:HIMS) looked like a fallen growth star earlier this year. The telehealth platform was hammered by…